Neuraxis Inc. (NYSE AMERICAN: NRXS)
$2.85
-0.1650 ( -5.48% ) 5.6K
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Market Data
Open
$2.85
Previous close
$3.01
Volume
5.6K
Market cap
$19.88M
Day range
$2.94 - $3.06
52 week range
$1.80 - $6.93
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 114 | Apr 16, 2024 |
8-k | 8K-related | 14 | Apr 16, 2024 |
8-k | 8K-related | 14 | Apr 09, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |
8-k | 8K-related | 15 | Mar 28, 2024 |
3 | Insider transactions | 1 | Mar 15, 2024 |
8-k | 8K-related | 44 | Mar 11, 2024 |
4 | Insider transactions | 1 | Feb 29, 2024 |
8-k | 8K-related | 18 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |